Comments on Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group, van Zandwijk et al., Eur J Cancer 1997, 33, 1759-1766. [electronic resource]
- European journal of cancer (Oxford, England : 1990) Sep 1998
- 1638 p. digital
Publication Type: Comment; Letter
0959-8049
Antineoplastic Agents--therapeutic use Carcinoma, Small Cell--therapy Clinical Trials, Phase III as Topic Humans Interferon-gamma--therapeutic use Lung Neoplasms--therapy Randomized Controlled Trials as Topic Recombinant Proteins